Korean J Dermatol.  2002 Dec;40(12):1543-1546.

Low-dose PUVA Photochemotherapy in a Patient with Both Localized Scleroderma and Vitiligo

Affiliations
  • 1Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea. dermy@hanmir.com

Abstract

The etiology of scleroderma remains uncertain, but several pathomechanisms have been suggested including vascular alterations with endothelial cell damage, disturbances in the control of collagen synthesis and autoimmune activity. The association with other autoimmune diseases such as thyroid disorder and vitiligo may favor the attribution of autoimmunity to its pathomechanism. But their association has been rarely reported. Psoralen plus ultraviolet A (PUVA) photochemotherapy is the most popular and effective therapeutic modality for vitiligo. And successful treatments of localized scleroderma with PUVA photochemotherapy have been reported, including topical, systemic, and bath PUVA. We report a case of successful treatment with low-dose systemic PUVA photochemotherapy for the patient, who has concurrently both the localized scleroderma and vitiligo.

Keyword

Localized scleroderma; Vitiligo; PUVA photochemotherapy

MeSH Terms

Autoimmune Diseases
Autoimmunity
Baths
Collagen
Endothelial Cells
Ficusin
Humans
Photochemotherapy*
Scleroderma, Localized*
Thyroid Gland
Vitiligo*
Collagen
Ficusin
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr